Analyst Ratings for LENZ Therapeutics Inc (LENZ)
LENZ Rating Summary
LENZ Price Target Summary
- Highest: $38.00 (H.C. Wainwright)
- Lowest: $7.00 (Piper Sandler)
- Average: $15.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.50 (+228.4%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
Avg. $ Target:
$15.50 (+228.4%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2026 | BofA Securities | Jason Gerberry | Downgrade | Neutral (Buy) |
7.00 (31.00) |
5.21 (4.72) |
-9.4% | Details |
| 5/12/2026 | Piper Sandler » Updated 8/12/2026 |
Biren Amin | Downgrade | Neutral (Overweight) |
7.00 (12.00) |
10.06 (4.72) |
-53.08% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
